← Back to Search

Exoskeleton

Keeogo for Neurologic Locomotion Disorder

N/A
Waitlist Available
Led By Arun Jayaraman, PT, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial visit (week 1); post testing (week 2)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether using a wearable robotic device (exoskeleton) during stair climbing training can help people who have recently had a stroke improve their ability to walk and climb stairs. The exoskeleton gives extra support and strength to the legs, making movement easier. Wearable exoskeletons are a relatively new technology that have shown promise in improving walking speed, balance, and overall mobility in post-stroke rehabilitation.

Eligible Conditions
  • Stroke
  • Neurologic Locomotion Disorder
  • Neurologic Gait Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial visit (week 1); post testing (week 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial visit (week 1); post testing (week 2) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Timed Stair Climb Test speed from baseline
Secondary study objectives
5-times Sit to Stand Test
GAITRite Data Collection

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1 ExoskeletonExperimental Treatment1 Intervention
Both training groups will undergo inpatient physical therapy of the same duration and intensity. Group 1 will complete stair training wearing the Keeogo Exoskeleton in inpatient physical therapy.
Group II: Group 2 Traditional TherapyActive Control1 Intervention
Group 2 will complete traditional stair training in inpatient physical therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Keeogo
2017
N/A
~20

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
18,010 Total Patients Enrolled
U.S. Department of EducationFED
86 Previous Clinical Trials
54,717 Total Patients Enrolled
Arun Jayaraman, PT, PhDPrincipal Investigator - Shirley Ryan Ability Lab
Shirley Ryan AbilityLab
23 Previous Clinical Trials
3,387 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top